Search Results - "KRUPP, L. B"

Refine Results
  1. 1

    Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial by KRUPP, L. B, HYMAN, L. G, GRIMSON, R, COYLE, P. K, MELVILLE, P, AHNN, S, DATTWYLER, R, CHANDLER, B

    Published in Neurology (24-06-2003)
    “…To determine whether post Lyme syndrome (PLS) is antibiotic responsive. The authors conducted a single-center randomized double-masked placebo-controlled trial…”
    Get full text
    Journal Article
  2. 2

    Dose comparison trial of sustained-release fampridine in multiple sclerosis by GOODMAN, A. D, BROWN, T. R, COHEN, J. A, KRUPP, L. B, SCHAPIRO, R, SCHWID, S. R, COHEN, R, MARINUCCI, L. N, BLIGHT, A. R

    Published in Neurology (07-10-2008)
    “…To examine the efficacy and safety of three different doses of sustained-release fampridine in people with multiple sclerosis (MS). This multicenter,…”
    Get full text
    Journal Article
  3. 3

    Social cognition in pediatric-onset multiple sclerosis (MS) by Charvet, LE, Cleary, RE, Vazquez, K, Belman, AL, Krupp, LB

    Published in Multiple sclerosis (01-10-2014)
    “…Background: Pediatric-onset multiple sclerosis (MS) patients represent a subpopulation who are diagnosed during the course of development. Social cognitive…”
    Get full text
    Journal Article
  4. 4

    Donepezil improved memory in multiple sclerosis in a randomized clinical trial by KRUPP, L. B, CHRISTODOULOU, C, MELVILLE, P, SCHERL, W. F, MACALLISTER, W. S, ELKINS, L. E

    Published in Neurology (09-11-2004)
    “…To determine the effect of donepezil in treating memory and cognitive dysfunction in multiple sclerosis (MS). This single-center double-blind…”
    Get full text
    Journal Article
  5. 5

    Younger children with MS have a distinct CSF inflammatory profile at disease onset by CHABAS, D, NESS, J, RODRIGUEZ, M, WEINSTOCK-GUTTMAN, B, KRUPP, L. B, WAUBANT, E, BELMAN, A, YEH, E. A, KUNTZ, N, GORMAN, M. P, STROBER, J. B, DE KOUCHKOVSKY, I, MCCULLOCH, C, CHITNIS, T

    Published in Neurology (02-02-2010)
    “…The clinical and MRI presentation differs between earlier- and later-onset pediatric multiple sclerosis (MS), whereas the effect of age on the CSF inflammatory…”
    Get full text
    Journal Article
  6. 6

    Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis by KRUPP, L. B, CHRISTODOULOU, C, SCHWID, S. R, WEINSTOCK-GUTTMAN, B, WESTERVELT, H. J, WISHART, H, MELVILLE, P, SCHERL, W. F, PAI, L.-Y, MUENZ, L. R, HE, D, BENEDICT, R. H. B, GOODMAN, A, RIZVI, S

    Published in Neurology (26-04-2011)
    “…The goal of this study was to determine if memory would be improved by donepezil as compared to placebo in a multicenter, double-blind, randomized clinical…”
    Get full text
    Journal Article
  7. 7

    Cognitive functioning in children and adolescents with multiple sclerosis by MACALLISTER, W. S, BELMAN, A. L, MILAZZO, M, WEISBROT, D. M, CHRISTODOULOU, C, SCHERL, W. F, PRESTON, T. E, CIANCIULLI, C, KRUPP, L. B

    Published in Neurology (26-04-2005)
    “…To examine cognitive functioning in children with multiple sclerosis (MS). The authors examined the neuropsychological profile of 37 children with a diagnosis…”
    Get full text
    Journal Article
  8. 8

    Longitudinal correlates of fatigue in multiple sclerosis by Patrick, E, Christodoulou, C, Krupp, LB

    Published in Multiple sclerosis (01-02-2009)
    “…Objective To determine the predictors of longitudinal changes in fatigue based on pain, mood, and neurological impairment across multiple sclerosis (MS)…”
    Get full text
    Journal Article
  9. 9

    Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network by Charvet, LE, O’Donnell, EH, Belman, AL, Chitnis, T, Ness, JM, Parrish, J, Patterson, M, Rodriguez, M, Waubant, E, Weinstock-Guttman, B, Krupp, LB

    Published in Multiple sclerosis (01-10-2014)
    “…Background: Approximately one-third of those with pediatric-onset multiple sclerosis (MS) experience cognitive impairment. Less is known concerning their…”
    Get full text
    Journal Article
  10. 10

    Protein expression profiles in pediatric multiple sclerosis: potential biomarkers by Rithidech, KN, Honikel, L, Milazzo, M, Madigan, D, Troxell, R, Krupp, LB

    Published in Multiple sclerosis (01-04-2009)
    “…The diagnosis of pediatric multiple sclerosis (MS) is challenging due to its low frequency and the overlap with other acquired childhood demyelinating…”
    Get full text
    Journal Article
  11. 11

    Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients by Christodoulou, C, Krupp, L B, Liang, Z, Huang, W, Melville, P, Roque, C, Scherl, W F, Morgan, T, MacAllister, W S, Li, L, Tudorica, L A, Li, X, Roche, P, Peyster, R

    Published in Neurology (10-06-2003)
    “…To relate neuropsychological performance to measures of cerebral injury in persons with MS selected for cognitive impairment. Participants were 37 individuals…”
    Get full text
    Journal Article
  12. 12

    Visual-cognitive processing deficits in pediatric multiple sclerosis by Smerbeck, AM, Parrish, J, Serafin, D, Yeh, EA, Weinstock-Guttman, B, Hoogs, M, Krupp, LB, Benedict, RHB

    Published in Multiple sclerosis (01-04-2011)
    “…Background: Children with multiple sclerosis (MS) can suffer significant cognitive deficits. This study investigates the sensitivity and validity in pediatric…”
    Get full text
    Journal Article
  13. 13

    Copy number variation in pediatric multiple sclerosis by McElroy, JP, Krupp, LB, Johnson, BA, McCauley, JL, Qi, Z, Caillier, SJ, Gourraud, PA, Yu, J, Nathanson, L, Belman, AL, Hauser, SL, Waubant, E, Hedges, DJ, Oksenberg, JR

    Published in Multiple sclerosis (01-07-2013)
    “…Background: Pediatric onset multiple sclerosis (MS) accounts for 2-4% of all MS. It is unknown whether the disease shares the same underlying pathophysiology…”
    Get full text
    Journal Article
  14. 14

    Fatigue therapy in multiple sclerosis : results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo by KRUPP, L. B, COYLE, P. K, DOSCHER, C, MILLER, A, CROSS, A. H, JANDORF, L, HALPER, J, JOHNSON, B, MORGANTE, L, GRIMSON, R

    Published in Neurology (01-11-1995)
    “…To determine the relative efficacy of amantadine, pemoline, and placebo in treatment of multiple sclerosis (MS)-related fatigue. Fatigue is a complication of…”
    Get full text
    Journal Article
  15. 15

    Remotely-delivered cognitive remediation in multiple sclerosis (MS): protocol and results from a pilot study by Charvet, LE, Shaw, MT, Haider, L, Melville, P, Krupp, LB

    “…Background Cognitive impairment represents a critical unmet treatment need in multiple sclerosis (MS). Cognitive remediation is promising but traditionally…”
    Get full text
    Journal Article
  16. 16

    The measurement of fatigue: a new instrument by Schwartz, J E, Jandorf, L, Krupp, L B

    Published in Journal of psychosomatic research (01-10-1993)
    “…Fatigue is a frequent medical symptom which has not been routinely measured. We present a 29-item fatigue assessment instrument, describe its psychometric…”
    Get more information
    Journal Article
  17. 17

    Are quantitative functional measures more sensitive to worsening MS than traditional measures? by SCHWID, S. R, GOODMAN, A. D, APATOFF, B. R, COYLE, P. K, JACOBS, L. D, KRUPP, L. B, MILLER, A. E, WENDE, K. E, BROWNSCHEIDLE, C. M

    Published in Neurology (26-12-2000)
    “…The authors used data collected prospectively during a multicenter trial in 133 patients with secondary progressive MS to assess the relative sensitivity of…”
    Get full text
    Journal Article
  18. 18

    A study of fatigue in systemic lupus erythematosus by Krupp, L B, LaRocca, N G, Muir, J, Steinberg, A D

    Published in Journal of rheumatology (01-11-1990)
    “…Fifty-nine patients with systemic lupus erythematosus were evaluated by questionnaires, histories, physical examinations and routine laboratory studies in…”
    Get more information
    Journal Article
  19. 19

    The psychosocial consequences of pediatric multiple sclerosis by MacAllister, W S, Boyd, J R, Holland, N J, Milazzo, M C, Krupp, L B

    Published in Neurology (17-04-2007)
    “…Although psychological distress and cognitive dysfunction are well documented in adults with multiple sclerosis (MS), they are poorly understood in children…”
    Get full text
    Journal Article
  20. 20

    Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy by Pan, J W, Coyle, P K, Bashir, K, Whitaker, J N, Krupp, L B, Hetherington, H P

    Published in Multiple sclerosis (01-05-2002)
    “…We used quantitative magnetic resonance (MR) spectroscopic imaging with T1-based image segmentation to evaluate the subtypes of multiple sclerosis (MS) (eight…”
    Get full text
    Journal Article